News

SCENIHR: DEHT future alternative

23.03.2016
European_Commission.svg

The SCENIHR report has been updated. It covers  safety assessment  of medical devices made of DEHP containing S-PVC. Grupa Azoty ZAK S.A. does not recognise a significant revision compared to the previous version. SCENIHR report underlines DEHP positive influence on stabilization of a blood in medical equipment. The report points out DEHT (Oxoviflex®) as a good future alternative plasticizer for medical purposes.

In this respect SCENIHR quotes Wirnitzer  histopathology of DEHT (Wirnitzer et al.2011). It states that accordingclinical and histopathology research DEHT doesn’t have an influence on liver, thyroid, reproductive function and organs in the highest doses of DEHT. Based on currently available data, DEHT is not genotoxic, so it is considered as one of the best potential alternative plasticisers in PVC medical devices. The SCENIHR report points though that alternative plasticizers are not as well tested, so further research is required for DEHT.

 

 

 

Full SCENIHR report covers  safety assessment  of medical devices made of DEHP containing S-PVC

More about Oxoviflex® (DEHT trademark of Grupa Azoty ZAK S.A.)

Kategorie: News